DK0760238T3 - Præparat, der kan indgives perkutant, til behandling af vandladningslidelse - Google Patents
Præparat, der kan indgives perkutant, til behandling af vandladningslidelseInfo
- Publication number
- DK0760238T3 DK0760238T3 DK95918735T DK95918735T DK0760238T3 DK 0760238 T3 DK0760238 T3 DK 0760238T3 DK 95918735 T DK95918735 T DK 95918735T DK 95918735 T DK95918735 T DK 95918735T DK 0760238 T3 DK0760238 T3 DK 0760238T3
- Authority
- DK
- Denmark
- Prior art keywords
- preparation
- treatment
- urinary disorders
- administered percutaneously
- percutaneously
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7076—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Botany (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP12816294 | 1994-05-18 | ||
PCT/JP1995/000946 WO1995031190A1 (fr) | 1994-05-18 | 1995-05-18 | Preparation administrable par voie percutanee pour le traitement des troubles de la miction |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0760238T3 true DK0760238T3 (da) | 2002-07-22 |
Family
ID=14977927
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK95918735T DK0760238T3 (da) | 1994-05-18 | 1995-05-18 | Præparat, der kan indgives perkutant, til behandling af vandladningslidelse |
Country Status (8)
Country | Link |
---|---|
US (1) | US5770221A (de) |
EP (1) | EP0760238B1 (de) |
KR (1) | KR970703137A (de) |
AU (1) | AU2454495A (de) |
DE (1) | DE69526437T2 (de) |
DK (1) | DK0760238T3 (de) |
ES (1) | ES2172584T3 (de) |
WO (1) | WO1995031190A1 (de) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5989586A (en) * | 1992-10-05 | 1999-11-23 | Cygnus, Inc. | Two-phase matrix for sustained release drug delivery device |
US5879701A (en) * | 1997-02-28 | 1999-03-09 | Cygnus, Inc. | Transdermal delivery of basic drugs using nonpolar adhesive systems and acidic solubilizing agents |
US5843472A (en) * | 1997-02-28 | 1998-12-01 | Cygnus, Inc. | Transdermal drug delivery sytem for the administration of tamsulosin, and related compositions and methods of use |
JP4073517B2 (ja) * | 1997-04-07 | 2008-04-09 | 久光製薬株式会社 | 経皮吸収貼付剤用粘着剤及び経皮吸収貼付剤 |
CA2336682C (en) * | 1998-07-07 | 2006-10-10 | Transdermal Technologies, Inc. | Compositions for rapid and non-irritating transdermal delivery of pharmaceutically active agents and methods for formulating such compositions and delivery thereof |
WO2000053184A1 (fr) * | 1999-03-11 | 2000-09-14 | Saitama Daiichi Pharmaceutical Co., Ltd. | Composition medicamenteuse a absorption percutanee |
WO2000064434A1 (fr) * | 1999-04-26 | 2000-11-02 | Lead Chemical Co., Ltd. | Preparations percutanees contenant de l'oxybutynine |
EP1203582A4 (de) * | 1999-08-09 | 2005-08-03 | Yamanouchi Pharma Co Ltd | Edizinische zusammenstellung zur behandlung von erkrankungen des unteren harnwegs |
AU7703700A (en) * | 1999-09-22 | 2001-04-24 | Merck & Co., Inc. | Treatment of lower urinary tract symptoms and pharmaceutical compositions for use therein |
US20030109819A1 (en) * | 1999-12-15 | 2003-06-12 | Kiyomi Tsuruda | Adhesive preparations |
JP4854163B2 (ja) * | 2000-04-18 | 2012-01-18 | 久光製薬株式会社 | 抗炎症剤含有貼付剤 |
US6914169B1 (en) * | 2000-05-19 | 2005-07-05 | Hisamitsu Pharmaceutical., Inc. | Patch agent |
US20020198215A1 (en) * | 2000-10-23 | 2002-12-26 | Lino Tavares | Terazosin transdermal device and methods |
US20040258741A1 (en) * | 2001-10-17 | 2004-12-23 | Takaaki Terahara | Percutaneous absorption preparations |
JP4354678B2 (ja) * | 2002-08-28 | 2009-10-28 | 久光製薬株式会社 | 貼付剤 |
TWI296531B (en) * | 2002-10-18 | 2008-05-11 | Hisamitsu Pharmaceutical Co | Transdermal adhesive preparations for topical administration of fentanyl |
WO2005011683A1 (ja) * | 2003-08-04 | 2005-02-10 | Kyorin Pharmaceutical Co., Ltd. | 経皮吸収型製剤 |
TWI335226B (en) * | 2003-10-20 | 2011-01-01 | Hisamitsu Pharmaceutical Co | Adhesive preparations |
DE10357321A1 (de) * | 2003-12-05 | 2005-07-21 | Tesa Ag | Hochtackige Klebmasse, Verfahren zu deren Herstellung und deren Verwendung |
DE102004009903A1 (de) | 2004-02-26 | 2005-09-22 | Grünenthal GmbH | Pflaster mit reduzierter Hautirritation |
JP5208348B2 (ja) * | 2004-05-13 | 2013-06-12 | 旭化成ファーマ株式会社 | ナフトピジルを含有する医薬 |
WO2006082888A1 (ja) * | 2005-02-03 | 2006-08-10 | Kyorin Pharmaceutical Co., Ltd. | 経皮吸収型製剤 |
WO2006118173A1 (ja) * | 2005-04-28 | 2006-11-09 | Ono Pharmaceutical Co., Ltd. | 経皮吸収製剤 |
JP4921739B2 (ja) * | 2005-08-10 | 2012-04-25 | 久光製薬株式会社 | 皮膚刺激を低減した貼付剤 |
WO2007021008A1 (ja) * | 2005-08-19 | 2007-02-22 | Dia Pharmaceutical Co., Ltd. | プラスターの製造方法及びその製造装置及びプラスタ-用ライナ- |
US20090155343A1 (en) | 2006-04-11 | 2009-06-18 | Nichiban Co., Ltd | Tamsulosin-Containing Transdermal Patch |
US20100092544A1 (en) * | 2008-10-14 | 2010-04-15 | Katsuhiro Okada | Adhesive composition for patch and use thereof |
WO2013081014A1 (ja) * | 2011-11-28 | 2013-06-06 | 株式会社 ケイ・エム トランスダーム | 貼付剤 |
WO2016088898A1 (ja) * | 2014-12-05 | 2016-06-09 | 株式会社 ケイ・エム トランスダーム | 皮膚貼付用粘着シートおよびそれを用いた経皮吸収製剤 |
WO2018026371A1 (en) * | 2016-08-04 | 2018-02-08 | Sunovion Pharmaceuticals Inc. | Dual nav1.2/5ht2a inhibitors for treating cns disorders |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4262003A (en) * | 1975-12-08 | 1981-04-14 | Alza Corporation | Method and therapeutic system for administering scopolamine transdermally |
DE3344691A1 (de) * | 1983-12-10 | 1985-06-20 | Bayer Ag, 5090 Leverkusen | Wirkstoffabgasesysteme |
JPS6145052A (ja) * | 1984-08-07 | 1986-03-04 | 有限会社 ▲カゲ▼山商事 | 桟瓦 |
EP0204968B1 (de) * | 1985-05-24 | 1989-09-27 | Beiersdorf Aktiengesellschaft | Nitro-Pflaster |
US4938759A (en) * | 1986-09-02 | 1990-07-03 | Alza Corporation | Transdermal delivery device having a rate controlling adhesive |
US4793337A (en) * | 1986-11-17 | 1988-12-27 | E. R. Squibb & Sons, Inc. | Adhesive structure and products including same |
US5059189A (en) * | 1987-09-08 | 1991-10-22 | E. R. Squibb & Sons, Inc. | Method of preparing adhesive dressings containing a pharmaceutically active ingredient |
JPH0725669B2 (ja) * | 1988-12-23 | 1995-03-22 | 日東電工株式会社 | 経皮投与用医薬製剤 |
US5508038A (en) * | 1990-04-16 | 1996-04-16 | Alza Corporation | Polyisobutylene adhesives for transdermal devices |
JP2869167B2 (ja) * | 1990-08-09 | 1999-03-10 | 日東電工株式会社 | 徐放性貼付製剤 |
JP3136413B2 (ja) * | 1991-02-22 | 2001-02-19 | リードケミカル株式会社 | 経皮吸収型頻尿・尿失禁治療剤 |
JPH04273818A (ja) * | 1991-02-28 | 1992-09-30 | Kissei Pharmaceut Co Ltd | 経皮投与製剤 |
CA2132865C (en) * | 1992-05-13 | 2003-12-02 | Eun S. Lee | Transdermal administration of oxybutynin |
US5380760A (en) * | 1993-11-19 | 1995-01-10 | Minnesota Mining And Manufacturing Company | Transdermal prostaglandin composition |
US5503843A (en) * | 1994-04-22 | 1996-04-02 | Flora Inc. | Transdermal delivery of alpha adrenoceptor blocking agents |
-
1995
- 1995-05-18 EP EP95918735A patent/EP0760238B1/de not_active Expired - Lifetime
- 1995-05-18 ES ES95918735T patent/ES2172584T3/es not_active Expired - Lifetime
- 1995-05-18 US US08/737,160 patent/US5770221A/en not_active Expired - Lifetime
- 1995-05-18 DK DK95918735T patent/DK0760238T3/da active
- 1995-05-18 WO PCT/JP1995/000946 patent/WO1995031190A1/ja active IP Right Grant
- 1995-05-18 DE DE69526437T patent/DE69526437T2/de not_active Expired - Lifetime
- 1995-05-18 AU AU24544/95A patent/AU2454495A/en not_active Abandoned
- 1995-05-18 KR KR1019960706510A patent/KR970703137A/ko not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP0760238B1 (de) | 2002-04-17 |
EP0760238A1 (de) | 1997-03-05 |
ES2172584T3 (es) | 2002-10-01 |
US5770221A (en) | 1998-06-23 |
DE69526437D1 (de) | 2002-05-23 |
DE69526437T2 (de) | 2002-10-31 |
EP0760238A4 (de) | 1998-06-03 |
WO1995031190A1 (fr) | 1995-11-23 |
AU2454495A (en) | 1995-12-05 |
KR970703137A (ko) | 1997-07-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0760238T3 (da) | Præparat, der kan indgives perkutant, til behandling af vandladningslidelse | |
DK1063990T3 (da) | Anvendelse af Biochanin-beriget ekstrakt til behandling af östrogen-associerede lidelser | |
EP1143956A3 (de) | Zusammensetzungen und verfahren zur behandlung von anorektalen krankheiten | |
DK1047428T3 (da) | Anvendelse af morpholinol til behandlingen af seksualforstyrrelser | |
NO20020133D0 (no) | Preparat for behandling av utvortes sekresjonsforstyrrelser | |
ZA200109073B (en) | Compositions for treatment of disorders of the oesophagus. | |
DK1112106T3 (da) | Serotonerge 5HT2-agonister til behandling af glaukom | |
NO20005884D0 (no) | Kombinasjonsterapi for behandling av bipolare forstyrrelser | |
HUP0103856A3 (en) | Pharmaceutical composition for the treatment of acute disorders | |
DK1352896T3 (da) | Adamantanderivater til behandling af inflammations-, immun- og hjertekarsygdomme | |
NO20004098L (no) | FremgangsmÕter og preparater for behandling av makrofag- formidlede lidelser | |
NO951761D0 (no) | Stabilt preparat for behandling av blodkoagulasjonssykdommer | |
HU9601854D0 (en) | Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders | |
DK0937055T3 (da) | Fremgangsmåde til fremstilling af d,I-alfa-tocopherol | |
DK1228028T3 (da) | Hydroxyicosatetraenoatsalte, præparater og fremgangsmåder til anvendelse til behandling af öjentörhedslidelser | |
PT1300084E (pt) | Composicaio para o tratamento de insuficiencias venosas cronicas melha. | |
DK1105390T3 (da) | Imidazo(1,2a)pyridinderivater til behandling af gastrointestinale sygdomme | |
NO20010456L (no) | Triazolopyridiner for behandling av trombose lidelser | |
DK0928183T3 (da) | Anvendelse af 1-hydroxy-2-pyridoner til behandling af seborrhoisk dermatitis | |
DE69735417D1 (de) | 2,5-dihydroxybenzylsulfonderivate zur behandlung von sexuellen störungen | |
DK1309322T3 (da) | Anvendelse af 3-benzoylphenyleddikesyrederivater til behandling af retinale lidelser | |
DK0983084T3 (da) | Anvendelse af hyaluronidase til fremstilling af et öjenpræparat til flydendegörelse af glaslegemet i behandlingen af öjenlidelser | |
NO991734D0 (no) | Pyrazolinoner for behandling av potensforstyrrelser | |
DK0935598T3 (da) | 5-heteroatom-alkylsubstituerede 3-oxopyrido(1,2-a)benzimidazol-4-carboxamidderivater egnede til behandling af sygdomme i centralnervesystemet | |
NO20005216D0 (no) | Sammensetning for behandling av eksterne sekresjonssykdommer unntatt hypolakrimasjon |